Trouble reading this e-mail? View it in your browser.

EFPIA
Newsletter
16 April 2015
Header
Header image
News

News

EFPIA Welcomes WHO Statement on Clinical Trials Data Disclosure
16 April 2015

EFPIA welcomes theWorld Health Organization’s Statement on Public Disclosure of Clinical Trial Results and is supportive of its assertion that “the registration of all interventional [...] Read more

From our blog

From our blog

A European Partnership Approach to Solving Drug Shortages
16 April 2015 by Faraz Kermani

Drug shortages across Europe are not commonplace, but when they occur, they can have a severely negative impact on patient health, specifically where no alternative therapies are available.

Speaking at the 27 annual DIA EuroMeeting in Paris, France, Pär Tellner, EFPIA Director of Regulatory affairs, acknowledged industry’s obligation to supply and emphasized that medicines manufacturers were working hard to understand why shortages occur.

Read more

Events calendar

Events Calendar

Countdown - 1 week: EFPIA Annual Meetings 3-5 June 2015
From 03/06/2015 to 05/06/2015 (Luxembourg)

Only 1 week to go - Register Urgently

EFPIA will be holding its 2015 Annual Meetings from 3 to 5 June in Luxembourg. The event provides an unparalleled opportunity to discuss the key issues driving the European pharmaceutical and healthcare agenda as well as network with senior industry and European stakeholders.

PROGRAMME

REGISTRATION

 

Read more

Events Calendar

FT Digital Health Summit Europe
On 10/06/2015 (London)

The Financial Times is delighted to announce the FT Digital Health Summit Europe: Delivering Scalable and Affordable Innovations, taking place on Wednesday 10th June, in London, UK. Digital [...] Read more

Events Calendar

EU/India Health Conference
On 29/04/2015 (New Delhi)

Universal health  overage is an integral part of a healthy society. That's why it is at the heart of Goal 3 within the UN Sustainable Development Goals - "Ensure healthy lives and promote well-being for all at all ages". But how can this be achieved in practice, in a time of resource constraints and increasing patient expectation? How can it be built in a way that meets the needs of today but is sustainable and scalable for the patients of tomorrow?

Read more

What we are reading

What we are reading

MEP backs new Parkinson's awareness campaign
16 April 2015 (The Parliament Magazine)

Around World Parkinson’s Day, we should recall that there are currently more than 1.2 million people living with Parkinson’s in Europe today, making it one of the most common neurodegenerative diseases. This figure shows no sign of slowing down, with the number of people living with the disease forecast to double by 2030 primarily as a result of our ageing population.

Read more

About EFPIA updates
Unsubscribe to be removed from this mailing list | Update your subscription

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 34 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.
Leopold Plaza Building
Rue du Trône 108
B-1050 Brussels (Belgium)
Tel: +32 (0)2 626 25 55
E-mail: communications@efpia.eu
Follow EFPIA
Twitter LinkedIn Youtube Google + Pinterest E-mail